SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (4891)11/6/2001 2:48:41 PM
From: Biomaven  Respond to of 52153
 
Thanks, Harry - I didn't catch the CC and I hadn't heard about the depression "kick-start." If this view is correct, it may show up in the script numbers (which I haven't tracked lately) as an increase in the ratio of new scripts to refills.

Eventual market size is still very unclear to me. If it starts to get wide use as a "super-caffeine" then Provigil may be only at the very start of its growth curve.

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News